Advertisement
Topics covered during the meeting include advances in skin tighteningtechnology, clinical outcomes using the deep contouring tip for Body Shapeprocedures and the new treatment for cellulite. Additionally research will bepresented on how Thermage technology may be applied for future applicationssuch as fat reduction.
Advertisement
The Thermage Symposium will be held on Thursday April 3rd at 7pm at theGaylord Palms Resort, Osceola B. The symposium will be moderated by JeffreyDover, M.D and will feature Robert Weiss, M.D, Karyn Grossman, M.D and SuzanneBruce, M.D. The symposium will cover how continual innovation has maintainedThermage technology as the gold standard in skin tightening and contouring forface and body. There will also be a discussion on how Thermage technology andthese new applications can be integrated into an aesthetic practice.
"Thermage is dedicated to continual innovation to expand our platform withnew applications and to drive the efficacy and value of our products to meetthe needs of our customers," said Stephen J. Fanning, Chairman of the Board,President and Chief Executive Officer at Thermage. "The clinical findingsbeing presented at ASLMS are a testament to our commitment to commercializeproducts that are based on thorough scientific and clinical research as wellas our long-standing partnerships with pre-eminent researchers andpractitioners in the field."
About Thermage
Thermage's innovative technologies provide unique non-invasive proceduresdesigned to smooth, tighten and contour skin, significantly expanding thenon-invasive aesthetic applications physicians can offer to the rapidlygrowing "anti-aging" market. For more information about Thermage, call1-510-259-7117 or log on to http://www.thermage.com.
This press release may contain forward-looking statements within themeaning of the U.S. Private Securities Litigation Reform Act of 1995.Forward-looking statements are based on management's current, preliminaryexpectations and are subject to risks and uncertainties, which may causeThermage's actual results to differ materially from the statements containedherein. Further information on potential risk factors that could affectThermage's business are detailed in the Company's Form 10-K for the periodended December 31, 2007. Undue reliance should not be placed onforward-looking statements, which speaks only as of the date they are made.Thermage undertakes no obligation to update publicly any forward-lookingstatements to reflect new information, events or circumstances after the datethey were made, or to reflect the occurrence of unanticipated events.
All our claims are based upon our FDA clearance for the non-invasivetreatment of wrinkles and rhytids, including the upper and lower eyelids, andfor the temporary improvement in the appearance of cellulite.
Side effects are generally mild and may include redness, swelling,blisters, bumps and rare instances of surface irregularities. Thermage, Inc.Thermage technology will be featured in the following sessions: -- Anne C. Chapas, M.D., Skin Rejuvenation Session April 3rd 8 a.m. - 12 p.m. -- Robert A. Weiss, M.D. Skin Rejuvenation Session April 3rd 8 a.m. - 12 p.m. -- Christopher Zachary, M.D. "Effects of Monopolar Radiofrequency on the subcutaneous fat layer in an animal model", Cutaneous Laser Surgery Session April 6th 8.55 a.m. Clinical studies accepted as poster presentations include: -- Sofia Rubbani, M.D. "Advances in Monopolar Radiofrequency
